HOXB2 and nasopharyngeal carcinoma: In the present study, we screened homeobox B2 (HOXB2) as a potential regulator of the progression and radioresistance of NPC with a comprehensive bioinformatics, which its expression in patient tissues was also increased by immunohistochemistry.